We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Integrins and Actions of Androgen in Breast Cancer.
- Authors
Tsai, Chung-Che; Yang, Yu-Chen S. H.; Chen, Yi-Fong; Huang, Lin-Yi; Yang, Yung-Ning; Lee, Sheng-Yang; Wang, Wen-Long; Lee, Hsin-Lun; Whang-Peng, Jacqueline; Lin, Hung-Yun; Wang, Kuan
- Abstract
Androgen has been shown to regulate male physiological activities and cancer proliferation. It is used to antagonize estrogen-induced proliferative effects in breast cancer cells. However, evidence indicates that androgen can stimulate cancer cell growth in estrogen receptor (ER)-positive and ER-negative breast cancer cells via different types of receptors and different mechanisms. Androgen-induced cancer growth and metastasis link with different types of integrins. Integrin αvβ3 is predominantly expressed and activated in cancer cells and rapidly dividing endothelial cells. Programmed death-ligand 1 (PD-L1) also plays a vital role in cancer growth. The part of integrins in action with androgen in cancer cells is not fully mechanically understood. To clarify the interactions between androgen and integrin αvβ3, we carried out molecular modeling to explain the potential interactions of androgen with integrin αvβ3. The androgen-regulated mechanisms on PD-L1 and its effects were also addressed.
- Subjects
ANDROGEN receptors; PROGRAMMED death-ligand 1; CANCER cell growth; INTEGRINS; BREAST cancer; ANDROGENS
- Publication
Cells (2073-4409), 2023, Vol 12, Issue 17, p2126
- ISSN
2073-4409
- Publication type
Article
- DOI
10.3390/cells12172126